Today

Indorama Ventures swings to USD 64.8m (THB 2.17bn) Q3 net profit on PET rebound

Indorama Ventures reported Q3 2026 net profit of USD 64.78m (THB 2,169.30m), against a net loss of USD 24.43m (THB 818.11m) a year earlier, as PET and chemicals margins recovered. Sales rose 22% to USD 3,982m (THB 133,345m) and EBITDA rose 65% to USD 410m (THB 13,724m), despite USD 13m (THB 449m) of restructuring and severance charges. EBITDA fell 37% from Q2 as integrated PET spreads normalised.

Why this mattersIndorama's profit recovery rests on PET and chemical spreads that already narrowed from Q2, a resin cost signal for bottle converters and beverage brand owners.

  • Q3 2026 net profit of USD 64.78m (THB 2,169.30m), against a net loss of USD 24.43m (THB 818.11m) a year earlier
  • Q3 sales up 22% to USD 3,982m (THB 133,345m); sales volume down 7% to 3.01m tonnes
  • Q3 EBITDA up 65% year on year to USD 410m (THB 13,724m), down 37% from Q2 2026
  • Combined PET and intermediate chemicals EBITDA up 88% to USD 258m (THB 8,651m)
  • Indovida packaging EBITDA up 45% to USD 30.4m (THB 1,017m) on 10% volume growth
  • Nine-month net profit of USD 158.7m (THB 5,314.23m), against a loss of USD 79.2m (THB 2,651.21m)
Indorama Ventures
Relevant to you?

Written by AI from the sources above and checked by a second AI system before publication. No human wrote or edited this story. How it is made.

Updates

  • 2026-11-10 · Edited before publication: None of the THB amounts had a USD conversion; all now converted at USD 1 = THB 33.49. Not in text_start, so removed: the India packaging merger timing and EBITDA effect, and the net debt and leverage figures. The Portfolio & Strategy topic is removed with them.
  • 2026-11-10 · Edited before publication: THB conversions are correct. There is no portfolio or strategy event; the story is about results and resin spreads, so the topics are corrected.